270 related articles for article (PubMed ID: 33266081)
1. Mouse Models of Sjögren's Syndrome with Ocular Surface Disease.
Masli S; Dartt DA
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266081
[TBL] [Abstract][Full Text] [Related]
2. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.
Ushio A; Arakaki R; Eguchi H; Hotta F; Yamada A; Kudo Y; Ishimaru N
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587293
[TBL] [Abstract][Full Text] [Related]
3. Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjögren's syndrome.
Contreras-Ruiz L; Regenfuss B; Mir FA; Kearns J; Masli S
PLoS One; 2013; 8(9):e75937. PubMed ID: 24086667
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-derived peptide attenuates Sjögren's syndrome-associated ocular surface inflammation in mice.
Contreras Ruiz L; Mir FA; Turpie B; Masli S
Clin Exp Immunol; 2017 Apr; 188(1):86-95. PubMed ID: 28033649
[TBL] [Abstract][Full Text] [Related]
5. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effects of rebamipide eyedrop administration on ocular lesions in a murine model of primary Sjögren's syndrome.
Arakaki R; Eguchi H; Yamada A; Kudo Y; Iwasa A; Enkhmaa T; Hotta F; Mitamura-Aizawa S; Mitamura Y; Hayashi Y; Ishimaru N
PLoS One; 2014; 9(5):e98390. PubMed ID: 24866156
[TBL] [Abstract][Full Text] [Related]
7. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM
Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjögren's syndrome.
Chen YT; Nikulina K; Lazarev S; Bahrami AF; Noble LB; Gallup M; McNamara NA
Am J Pathol; 2010 Sep; 177(3):1333-43. PubMed ID: 20696775
[TBL] [Abstract][Full Text] [Related]
9. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated Marginal Zone B Cell Compartment in a Mouse Model of Sjögren's Syndrome with Ocular Inflammation.
Singh N; Chin I; Gabriel P; Blaum E; Masli S
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314337
[TBL] [Abstract][Full Text] [Related]
11. Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice.
Turpie B; Yoshimura T; Gulati A; Rios JD; Dartt DA; Masli S
Am J Pathol; 2009 Sep; 175(3):1136-47. PubMed ID: 19700744
[TBL] [Abstract][Full Text] [Related]
12. Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjögren's syndrome.
Chen FY; Lee A; Ge S; Nathan S; Knox SM; McNamara NA
PLoS One; 2017; 12(9):e0184916. PubMed ID: 28926640
[TBL] [Abstract][Full Text] [Related]
13. Ophthalmologic Manifestations of Primary Sjögren's Syndrome.
Roszkowska AM; Oliverio GW; Aragona E; Inferrera L; Severo AA; Alessandrello F; Spinella R; Postorino EI; Aragona P
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33806489
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 receptor mediates the interplay between CD4+ T cells and ocular resident cells to promote keratinizing squamous metaplasia in Sjögren's syndrome.
Chen YT; Lazarev S; Bahrami AF; Noble LB; Chen FY; Zhou D; Gallup M; Yadav M; McNamara NA
Lab Invest; 2012 Apr; 92(4):556-70. PubMed ID: 22231738
[TBL] [Abstract][Full Text] [Related]
15. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
[TBL] [Abstract][Full Text] [Related]
16. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
Beckman KA; Luchs J; Milner MS; Ambrus JL
Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
[TBL] [Abstract][Full Text] [Related]
17. Systemic manifestations of primary Sjögren's syndrome in the NOD.B10Sn-H2
Kiripolsky J; Shen L; Liang Y; Li A; Suresh L; Lian Y; Li QZ; Gaile DP; Kramer JM
Clin Immunol; 2017 Oct; 183():225-232. PubMed ID: 28526333
[TBL] [Abstract][Full Text] [Related]
18. Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice.
De Paiva CS; Hwang CS; Pitcher JD; Pangelinan SB; Rahimy E; Chen W; Yoon KC; Farley WJ; Niederkorn JY; Stern ME; Li DQ; Pflugfelder SC
Rheumatology (Oxford); 2010 Feb; 49(2):246-58. PubMed ID: 20007286
[TBL] [Abstract][Full Text] [Related]
19. Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye.
Stern ME; Gao J; Schwalb TA; Ngo M; Tieu DD; Chan CC; Reis BL; Whitcup SM; Thompson D; Smith JA
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2609-14. PubMed ID: 12147592
[TBL] [Abstract][Full Text] [Related]
20. Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3.
Nguyen CQ; Kim H; Cornelius JG; Peck AB
J Immunol; 2007 Aug; 179(4):2318-29. PubMed ID: 17675493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]